loading
Precedente Chiudi:
$11.87
Aprire:
$11.89
Volume 24 ore:
149.52K
Relative Volume:
0.90
Capitalizzazione di mercato:
$621.61M
Reddito:
-
Utile/perdita netta:
$-119.67M
Rapporto P/E:
-8.855
EPS:
-1.4105
Flusso di cassa netto:
$-97.30M
1 W Prestazione:
+8.80%
1M Prestazione:
-10.47%
6M Prestazione:
-0.24%
1 anno Prestazione:
+109.56%
Intervallo 1D:
Value
$11.84
$12.61
Intervallo di 1 settimana:
Value
$11.30
$13.05
Portata 52W:
Value
$6.06
$16.91

Mineralys Therapeutics Inc Stock (MLYS) Company Profile

Name
Nome
Mineralys Therapeutics Inc
Name
Telefono
(888) 378-6240
Name
Indirizzo
150 N. RADNOR CHESTER ROAD, RADNOR
Name
Dipendente
28
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-12
Name
Ultimi documenti SEC
Name
MLYS's Discussions on Twitter

Confronta MLYS con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
MLYS 12.49 621.61M 0 -119.67M -97.30M -1.4105
VRTX 450.97 116.38B 10.63B -479.80M -1.35B 13.33
REGN 738.00 82.09B 13.85B 4.65B 3.32B 35.06
ARGX 605.92 36.14B 1.86B -40.29M -1.28B -4.16
ALNY 244.89 31.59B 2.09B -332.26M 16.06M -4.14
BNTX 113.13 27.25B 3.30B -501.07M 1.03B 11.54

Mineralys Therapeutics Inc Stock (MLYS) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2023-03-07 Iniziato BofA Securities Buy
2023-03-07 Iniziato Credit Suisse Outperform
2023-03-07 Iniziato Evercore ISI Outperform
2023-03-07 Iniziato Guggenheim Buy
2023-03-07 Iniziato Stifel Buy
2023-03-07 Iniziato Wells Fargo Overweight
Mostra tutto

Mineralys Therapeutics Inc Borsa (MLYS) Ultime notizie

pulisher
Nov 20, 2024

Mineralys Therapeutics Reports Q3 2024 Results and Clinical Progress - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Mineralys Therapeutics to Participate in Goldman Sachs Healthcare Conference - MSN

Nov 20, 2024
pulisher
Nov 18, 2024

Mineralys Therapeutics Set to Engage with Investors at Key Conferences - MSN

Nov 18, 2024
pulisher
Nov 14, 2024

Mineralys Therapeutics Inc (MLYS) Quarterly 10-Q Report - Quartzy

Nov 14, 2024
pulisher
Nov 14, 2024

What is Lifesci Capital's Forecast for MLYS FY2024 Earnings? - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

HC Wainwright Analysts Decrease Earnings Estimates for MLYS - MarketBeat

Nov 14, 2024
pulisher
Nov 13, 2024

(MLYS) Trading Signals - Stock Traders Daily

Nov 13, 2024
pulisher
Nov 13, 2024

Mineralys therapeutics CMO sells shares worth $75,398 By Investing.com - Investing.com Australia

Nov 13, 2024
pulisher
Nov 13, 2024

MineralysTargeting Aldosterone To Combat Obesity-Driven Hypertension And Kidney Disease - RTTNews

Nov 13, 2024
pulisher
Nov 12, 2024

Mineralys Therapeutics Announces Q3 2024 Results and Updates - Yahoo Finance

Nov 12, 2024
pulisher
Nov 12, 2024

Mineralys Therapeutics' (MLYS) "Buy" Rating Reiterated at HC Wainwright - MarketBeat

Nov 12, 2024
pulisher
Nov 12, 2024

Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q3 2024 Earnings Call Transcript - MSN

Nov 12, 2024
pulisher
Nov 11, 2024

Mineralys Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 11, 2024
pulisher
Nov 11, 2024

Mineralys Therapeutics reports Q3 EPS ($1.13), consensus (83c) - TipRanks

Nov 11, 2024
pulisher
Nov 11, 2024

Mineralys Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update - The Manila Times

Nov 11, 2024
pulisher
Nov 09, 2024

David Malcom Rodman Sells 25,482 Shares of Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Stock - MarketBeat

Nov 09, 2024
pulisher
Nov 08, 2024

Mineralys Therapeutics' chief medical officer sells $383,065 in stock - Investing.com

Nov 08, 2024
pulisher
Nov 07, 2024

Mineralys Therapeutics to Announce Third-Quarter 2024 Financial Results - MyChesCo

Nov 07, 2024
pulisher
Nov 05, 2024

Mineralys Therapeutics (MLYS) to Release Quarterly Earnings on Monday - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

Mineralys Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewswire

Nov 05, 2024
pulisher
Nov 05, 2024

Mineralys Therapeutics (MLYS) to Present at Three Major Healthcare Conferences | MLYS Stock News - StockTitan

Nov 05, 2024
pulisher
Nov 04, 2024

Mineralys Therapeutics to Announce Third Quarter 2024 - GlobeNewswire

Nov 04, 2024
pulisher
Nov 04, 2024

Mineralys Therapeutics to Announce Third Quarter 2024 Financial Results and Host Conference Call on Monday, November 11, 2024 - Marketscreener.com

Nov 04, 2024
pulisher
Nov 04, 2024

Mineralys Therapeutics’ (MLYS) “Buy” Rating Reaffirmed at HC Wainwright - Defense World

Nov 04, 2024
pulisher
Nov 03, 2024

Objective long/short (MLYS) Report - Stock Traders Daily

Nov 03, 2024
pulisher
Nov 02, 2024

Mineralys Therapeutics Completes Enrollment Ahead of Schedule in Pivotal Hypertension Trial - MSN

Nov 02, 2024
pulisher
Oct 31, 2024

Mineralys Therapeutics (NASDAQ:MLYS) Receives "Buy" Rating from HC Wainwright - MarketBeat

Oct 31, 2024
pulisher
Oct 30, 2024

Mineralys Therapeutics : Corporate Overview October 2024 - Marketscreener.com

Oct 30, 2024
pulisher
Oct 30, 2024

Mineralys Therapeutics Advances Lorundrostat Trial Progress - TipRanks

Oct 30, 2024
pulisher
Oct 30, 2024

Mineralys Therapeutics Completes Enrollment Ahead of - GlobeNewswire

Oct 30, 2024
pulisher
Oct 30, 2024

Mineralys Therapeutics Completes Enrollment Ahead of Schedule in Launch-HTN, the Second Pivotal Trial of Lorundrostat for the Treatment of Hypertension - The Manila Times

Oct 30, 2024
pulisher
Oct 29, 2024

Positive Trial Data on Symplicity RDN System Likely to Support MDT Stock - MSN

Oct 29, 2024
pulisher
Oct 25, 2024

Context Therapeutics to Engage Investors at November Conferences - MyChesCo

Oct 25, 2024
pulisher
Oct 24, 2024

Mineralys Therapeutics to Host Virtual Event on Hypertension Treatment Advances - MyChesCo

Oct 24, 2024
pulisher
Oct 23, 2024

When the Price of (MLYS) Talks, People Listen - Stock Traders Daily

Oct 23, 2024
pulisher
Oct 22, 2024

Mineralys to Host Virtual KOL Event on the Unmet Medical Need in Uncontrolled and Resistant Hypertension, and Lorundrostat as a Potential Treatment on October 30, 2024 - The Manila Times

Oct 22, 2024
pulisher
Oct 22, 2024

Mineralys to Host Virtual KOL Event on the Unmet Medical - GlobeNewswire

Oct 22, 2024
pulisher
Oct 20, 2024

We're Not Very Worried About Mineralys Therapeutics' (NASDAQ:MLYS) Cash Burn Rate - Yahoo Finance

Oct 20, 2024
pulisher
Oct 17, 2024

Hypertension Clinical Trials 2024: FDA Approvals, Medication, - openPR

Oct 17, 2024
pulisher
Oct 17, 2024

Hypertension Clinical Trials 2024: FDA Approvals, Medication, Therapies, MOA, ROA, Companies by DelveInsight | Quantum Genomics, CinCor Pharma, Mineralys Therapeutics, Alnylam Therapeutics, Novartis - The Globe and Mail

Oct 17, 2024
pulisher
Oct 16, 2024

Mineralys Therapeutics CEO sells $206,433 in stock - Investing.com

Oct 16, 2024
pulisher
Oct 16, 2024

Mineralys Therapeutics CEO sells $206,433 in stock By Investing.com - Investing.com Canada

Oct 16, 2024
pulisher
Oct 16, 2024

Mineralys therapeutics CFO Adam Levy sells $146,003 in stock By Investing.com - Investing.com South Africa

Oct 16, 2024
pulisher
Oct 16, 2024

Mineralys therapeutics CFO Adam Levy sells $146,003 in stock - Investing.com

Oct 16, 2024
pulisher
Oct 15, 2024

Mineralys Therapeutics Inc (MLYS) CEO Jon Congleton Sells 15,271 Shares - GuruFocus.com

Oct 15, 2024
pulisher
Oct 15, 2024

Insider Sale: CFO Adam Levy Sells Shares of Mineralys Therapeuti - GuruFocus.com

Oct 15, 2024
pulisher
Oct 15, 2024

Adam Scott Levy Sells 10,757 Shares of Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Stock - MarketBeat

Oct 15, 2024

Mineralys Therapeutics Inc Azioni (MLYS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$71.72
price up icon 1.89%
$19.00
price up icon 3.15%
$41.11
price up icon 7.48%
$372.89
price up icon 1.51%
$190.51
price down icon 2.08%
$113.13
price up icon 4.53%
Capitalizzazione:     |  Volume (24 ore):